Review
Immunology
Like Zhao, Xianda Hu, Fei Xiao, Xuan Zhang, Lidan Zhao, Min Wang
Summary: Nucleic acid autoantibodies, increased levels of interferon, and hyperactivation of immune cells are important factors in the development of systemic lupus erythematosus (SLE). Mitochondrial reactive oxygen species (mROS), produced during cellular energy generation, play a crucial role in regulating cell activation and differentiation, as well as the antigenicity of oxidized nucleoids within mitochondria. Recent research has focused on using mROS scavengers and restoring defective mitophagy to address mitochondrial redox imbalance in SLE. However, the underlying mechanisms of how oxidative stress-related mitochondrial molecules influence cell fate at the molecular level are still unknown.
FRONTIERS IN IMMUNOLOGY
(2022)
Review
Immunology
Zhu Yan, Qin Chen, Yumin Xia
Summary: Systemic lupus erythematosus (SLE) is a complex autoimmune disease that requires treatment with immunosuppressants. Oxidative stress plays a role in the inflammatory and cellular defects seen in SLE, with oxidative modifications of proteins, lipids, and DNA contributing to immune dysregulation. Detecting inflammatory and cellular markers is crucial for assessing oxidative stress levels accurately. Pharmacological approaches targeting oxidative stress have shown promise in treating SLE. This review examines the involvement of oxidative stress in the pathogenesis and management of SLE.
JOURNAL OF INFLAMMATION RESEARCH
(2023)
Article
Hematology
Yuqing Song, Yuelun Zhang, Zhuo Li, Jing Liu, Juan Xiao, Hongmei Song
Summary: This study aimed to explore the potential risk factors for the development from ITP to SLE in Chinese children through statistical analysis. The findings suggest that older age and hypocomplementemia are potential risk factors for the development from ITP to SLE.
ANNALS OF HEMATOLOGY
(2022)
Editorial Material
Ophthalmology
Manolya Kara, Gul Nihal Ozdemir, Mehmet Tasdemir, Serap Ata, Belma Karini, Eldar Valiyev, Ilknur Tugal Tutkun, Gulsen Kose, Ozan Ozkaya
Summary: This article presents a case of an 11-year-old girl with Bartonella neuroretinitis who benefitted from high-dose methylprednisolone and antibiotics. Further research is needed to determine the optimal dose and duration of corticosteroid treatment for Bartonella neuroretinitis.
EUROPEAN JOURNAL OF OPHTHALMOLOGY
(2023)
Review
Immunology
Diana C. Quintero-Gonzalez, Marcela Munoz-Urbano, G. Vasquez
Summary: Systemic lupus erythematosus (SLE) is a heterogeneous, multisystemic autoimmune disease characterized by loss of self-tolerance, chronic inflammation, and mitochondrial dysfunction, among other factors.
Review
Immunology
Zhou She, Cuifang Li, Feifeng Wu, Jueyi Mao, Min Xie, Marady Hun, Amin Sheikh Abdirahman, Senlin Luo, Wuqing Wan, Jidong Tian, Chuan Wen
Summary: Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by multisystemic and multi-organ involvement. The role of B1 cells in SLE remains unclear, but understanding their mechanism can provide new insights into the pathogenesis and treatment of SLE.
FRONTIERS IN IMMUNOLOGY
(2022)
Review
Biochemistry & Molecular Biology
Ryo Hisada, Tatsuya Atsumi
Summary: Despite advances in treatment, thrombosis remains the leading cause of death in SLE. aPL are the main triggers of thrombosis in SLE patients, with a frequency of approximately 30-40%. Lupus anticoagulant, anticardiolipin, anti-beta 2-glycoprotein I antibodies, and non-criteria aPL are risk factors for thrombosis in SLE. Multiple positivity for aPL and calculated scores can predict the risk of thrombosis. Treatment with anticoagulants and/or low-dose aspirin may be appropriate for aPL-positive SLE patients.
Article
Immunology
Jamil A. Al-Mughales
Summary: This study aimed to explore the pathogenic significance of ANA patterns in SLE patients. The speckled and homogeneous patterns were found to be the most common, and they were associated with other immune markers. Peripheral, mixed, and speckled patterns showed higher levels of immune markers, indicating a potential prognostic value in SLE.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Rheumatology
Bogdan Penev, Georgi Vasilev, Ekaterina Ivanova Todorova, Kalina Tumangelova-Yuzeir, Ekaterina Kurteva, Simeon Monov, Dobroslav Kyurkchiev
Summary: This cross-sectional study investigates the differences in clinical features, external risk factors, and immunological profiles between first-degree relatives of SLE patients, healthy individuals, and SLE patients. The study finds that first-degree relatives have higher titers of antinuclear autoantibodies, more specific staining immunofluorescent patterns, and more autoantibody specificities compared to healthy controls. Some clinical features are associated with higher ANA titers and specific antibodies.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES
(2023)
Article
Immunology
Ming-long Cai, Lan Gui, He Huang, Yu-kun Zhang, Li Zhang, Zhu Chen, Yu-jun Sheng
Summary: This study revealed heterogeneity in the pathogenesis of SLE between male and female patients, with male SLE showing higher levels of neutrophil activation. These findings provide a basis for the development of gender-specific treatments.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Rheumatology
Soo Min Ahn, Eun-Ji Choi, Ji Seon Oh, Yong-Gil Kim, Chang-Keun Lee, Bin Yoo, Seokchan Hong
Summary: This study aimed to investigate the clinical characteristics and risk factors for the development of systemic lupus erythematosus (SLE) in patients with primary immune thrombocytopenia (ITP). The results showed that young age, organ bleeding, and positive antinuclear antibody (ANA) were significantly associated with the development of SLE. Close follow-up is recommended for patients with primary ITP, especially those with the mentioned risk factors.
ARTHRITIS RESEARCH & THERAPY
(2022)
Article
Medicine, General & Internal
Chun-Chun Gau, Min-Hua Tseng, Chao-Yi Wu, Huang-Yu Yang, Jing-Long Huang
Summary: In pediatric-onset SLE patients, the presence of ANCAs tends to be associated with hematuria and an absence of typical renal immunofluorescence histology. However, there was no significant difference in clinical presentations and treatment outcomes between patients with and without ANCAs.
FRONTIERS IN MEDICINE
(2021)
Review
Immunology
Aleida Susana Castellanos Gutierrez, Francesc Figueras, Diana M. Morales-Prieto, Ekkehard Schleussner, Gerard Espinosa, Nuria Banos
Summary: Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease that mainly affects women of childbearing age. During pregnancy, SLE is associated with a higher risk of perinatal morbidity and mortality. Several studies have suggested that placental dysfunction may play a crucial role in this association.
FRONTIERS IN IMMUNOLOGY
(2022)
Article
Immunology
Haoguang Li, Xiuling Zhang, Jingjing Shang, Xueqin Feng, Le Yu, Jie Fan, Jie Ren, Rongwei Zhang, Xinwang Duan
Summary: This study investigated the molecular characteristics of NETs-related genes (NRGs) in systemic lupus erythematosus (SLE) through bioinformatics analysis. Eight differentially expressed NRGs were identified and HMGB1, ITGB2, and CREB5 were selected as hub genes. These hub genes showed significant diagnostic value for SLE and three distinct NETs-related sub-clusters were identified. This study provides new insights into the molecular characteristics of NRGs in SLE and identifies potential biomarkers and molecular clusters.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Rheumatology
Robin Arcani, Daniel Bertin, Nathalie Bardin, Karin Mazodier, Rodolphe Jean, Pierre Suchon, Geoffroy Venton, Aurelie Daumas, Estelle Jean, Patrick Villani, Gilles Kaplanski, Pierre-Andre Jarrot
Summary: The study shows that anti-NuMA antibodies are mainly associated with pSS and SLE, and patients with these antibodies have less severe clinical profiles and require less treatment. Anti-NuMA antibodies may be a useful diagnostic marker when other auto-antibodies are negative and could indicate a good prognosis in autoimmune diseases.
Article
Environmental Sciences
Bianca H. Ventura Fernandes, Natalia Martins Feitosa, Ana Paula Barbosa, Camila Gasque Bomfim, Anali M. B. Garnique, Ivana F. Rosa, Maira S. Rodrigues, Lucas B. Doretto, Daniel F. Costa, Bruno Camargo-dos-Santos, Gabrielli A. Franco, Joao Favero Neto, Juliana Sartori Lunardi, Marina Sanson Bellot, Nina Pacheco Capelini Alves, Camila C. Costa, Mayumi F. Aracati, Leticia F. Rodrigues, Rafaela Hemily Cirilo, Raul Marcelino Colagrande, Francisco I. F. Gomes, Rafael T. Nakajima, Marco A. A. Belo, Percilia Cardoso Giaquinto, Susana Luporini de Oliveira, Silas Fernandes Eto, Dayanne Carla Fernandes, Wilson G. Manrique, Gabriel Conde, Roberta R. C. Rosales, Iris Todeschini, Ilo Rivero, Edgar Llontop, German G. Sgro, Gabriel Umaji Oka, Natalia Fernanda Bueno, Fausto K. Ferraris, Mariana T. Q. de Magalhaes, Renata J. Medeiros, Juliana M. Mendonca-Gomes, Mara Souza Junqueira, Katia Conceicao, Leticia Gomes de Pontes, Antonio Condino-Neto, Andrea C. Perez, Leonardo J. G. Barcellos, Jose Dias Correa Junior, Erick Gustavo Dorlass, Niels O. S. Camara, Edison Luiz Durigon, Fernando Q. Cunha, Rafael H. Nobrega, Glaucia M. Machado-Santelli, Chuck S. Farah, Flavio P. Veras, Jorge Galindo-Villegas, Leticia Costa-Lotufo, Thiago M. Cunha, Roger Chammas, Luciani R. Carvalho, Cristiane R. Guzzo, Guilherme Malafaia, Ives Charlie-Silva
Summary: This study found that injection of SARS-CoV-2 Spike protein rSpike in zebrafish resulted in mortality and adverse effects on liver, kidney, ovary, and brain tissues, with a survival rate of 78.6%. The conserved genetic homology between zebrafish and humans may contribute to the intense toxic effects observed. The results highlight the potential of zebrafish as an animal model for translational COVID-19 research and for understanding ecotoxicological impacts, vaccine responses, and therapeutic approaches.
SCIENCE OF THE TOTAL ENVIRONMENT
(2022)
Article
Cell Biology
Marjorie C. Pontelli, Italo A. Castro, Ronaldo B. Martins, Leonardo La Serra, Flavio P. Veras, Daniele C. Nascimento, Camila M. Silva, Ricardo S. Cardoso, Roberta Rosales, Rogerio Gomes, Thais M. Lima, Juliano P. Souza, Brenda C. Vitti, Diego B. Caetite, Mikhael H. F. de Lima, Spencer D. Stumpf, Cassandra E. Thompson, Louis-Marie Bloyet, Juliana E. Toller-Kawahisa, Marcela C. Giannini, Leticia P. Bonjorno, Maria I. F. Lopes, Sabrina S. Batah, Li Siyuan, Rodrigo Luppino-Assad, Sergio C. L. Almeida, Fabiola R. Oliveira, Maira N. Benatti, Lorena L. F. Pontes, Rodrigo C. Santana, Fernando C. Vilar, Maria Auxiliadora-Martins, Pei-Yong Shi, Thiago M. Cunha, Rodrigo T. Calado, Jose C. Alves-Filho, Dario S. Zamboni, Alexandre T. Fabro, Paulo Louzada-Junior, Rene D. R. Oliveira, Sean P. J. Whelan, Fernando Q. Cunha, Eurico Arruda
Summary: SARS-CoV-2 infection can lead to lymphocytopenia and infect immune cells such as monocytes, B cells, and T cells, resulting in T cell apoptosis. Additionally, SARS-CoV-2 is frequently detected in monocytes and B cells from COVID-19 patients.
JOURNAL OF MOLECULAR CELL BIOLOGY
(2022)
Article
Cell Biology
Laura Brandolini, Michele d'Angelo, Rubina Novelli, Vanessa Castelli, Cristina Giorgio, Anna Sirico, Pasquale Cocchiaro, Francesco D'Egidio, Elisabetta Benedetti, Claudia Cristiano, Antonella Bugatti, Anna Ruocco, Pier Giorgio Amendola, Carmine Talarico, Candida Manelfi, Daniela Iaconis, Andrea Beccari, Andreza U. Quadros, Thiago M. Cunha, Arnaldo Caruso, Roberto Russo, Annamaria Cimini, Andrea Aramini, Marcello Allegretti
Summary: This study discovered that paclitaxel can bind and activate C5a receptor 1 (C5aR1), which is crucial in the development of chemotherapy-induced peripheral neuropathy (CIPN) and hypersensitivity reactions (HSRs). In vitro studies and animal experiments confirmed the effectiveness of C5aR1 inhibition in protecting against neuropathological effects and reducing CIPN symptoms. Additionally, C5aR1 inhibition can counteract paclitaxel-induced hypersensitivity reactions. Thus, C5aR1 is identified as a potential pharmacological target for the prevention and treatment of CIPN and HSRs induced by paclitaxel.
CELL DEATH & DISEASE
(2022)
Article
Immunology
Thaiane Pinto Moreira, Carla Daiane Ferreira de Sousa, Victor Rodrigues de Melo Costa, Celso Martins Queiroz-Junior, Franciele Martins Santos, Caio Santos Bonilha, Lisia Maria Esper, Mauricio Lacerda Nogueira, Thiago Mattar Cunha, Mauro Martins Teixeira, Vivian Vasconcelos Costa, Daniele da Gloria de Souza
Summary: This study describes a novel mouse model of CHIKV infection and evaluates the role of tumour necrosis factor in the disease's pathogenesis. It shows that TNF plays a dual role in viral clearance and driving tissue damage and hypernociception. Therefore, TNF inhibitors may have therapeutic benefits, but viral levels must be monitored and used in combination with antiviral drugs when treating CHIKV-infected patients.
Article
Multidisciplinary Sciences
Leticia de Almeida, Alexandre L. N. da Silva, Tamara S. Rodrigues, Samuel Oliveira, Adriene Y. Ishimoto, Amanda A. Seribelli, Amanda Becerra, Warrison A. Andrade, Marco A. Ataide, Camila C. S. Caetano, Keyla S. G. de Sa, Natalia Pelisson, Ronaldo B. Martins, Juliano de Paula Souza, Eurico Arruda, Sabrina S. Batah, Ricardo Castro, Fabiani G. Frantz, Fernando Q. Cunha, Thiago M. Cunha, Alexandre T. Fabro, Larissa D. Cunha, Paulo Louzada-Junior, Rene D. R. de Oliveira, Dario S. Zamboni
Summary: This study identifies niclosamide as a potential FDA-approved drug for treating COVID-19 by inhibiting inflammasome activation and SARS-CoV-2 replication. Niclosamide shows strong inhibitory effects on inflammasome activation in human monocytes and PBMCs from COVID-19 patients in vitro, as well as in an in vivo mouse model of SARS-CoV-2 infection.
Article
Cell Biology
Patricia Brito Rodrigues, Giovanni Freitas Gomes, Monara K. S. C. Angelim, Gabriela F. Souza, Stefanie Primon Muraro, Daniel A. Toledo-Teixeira, Bruna Amanda Cruz Rattis, Amanda Stephane Passos, Lais Passarielo Pral, Vinicius de Rezende Rodovalho, Arilson Bernardo dos Santos P. Gomes, Valquiria Aparecida Matheus, Andre Saraiva Leao Marcelo Antunes, Fernanda Crunfli, Krist Helen Antunes, Ana Paula Duarte de Souza, Silvio Roberto Consonni, Luiz Osorio Leiria, Jose Carlos Alves-Filho, Thiago M. Cunha, Pedro M. M. Moraes-Vieira, Jose Luiz Proenca-Modena, Marco Aurelio R. Vinolo
Summary: Clinical and experimental data suggest that SARS-CoV-2 infection leads to changes in gut microbiota. However, the relevance of these changes remains unclear. This study examined the impact of microbiota depletion on the clinical and immunological responses of mice to SARS-CoV-2 infection. The results showed that microbiota depletion had no effect on the infection.
Article
Cell Biology
Vanessa de Fatima Borges, Leticia Selinger Galant, Alexandre Kanashiro, Fernanda Vargas e Silva Castanheira, Valter Vinicius Silva Monteiro, Diego angelo Duarte, Filipe Camargo Rodrigues, Camila Meirelles de Souza Silva, Ayda Henriques Schneider, Guilherme Cesar Martelossi Cebinelli, Mikhael Haruo Fernandes de Lima, Joao Paulo de Biaso Viola, Thiago Mattar Cunha, Claudio Miguel da Costa Neto, Jose Carlos Farias Alves-Filho, Andre Sampaio Pupo, Fernando de Queiroz Cunha
Summary: This study investigated the effects of FK506 on sepsis immunopathology and found that FK506 treatment resulted in failed neutrophil migration, leading to increased bacteremia and systemic inflammatory response, causing higher organ damage and mortality rates.
INFLAMMATION RESEARCH
(2023)
Article
Cell Biology
Marcelo Franchin, Thaise Mayumi Taira, Douglas da Silva Prado, Cesar Augusto Speck Hernandez, Fabio Bonifacio de Andrade, Henrique Ballassini Abdalla, Marcelo Henrique Napimoga, Thiago Mattar Cunha, Sandra Yasuyo Fukada, Pedro Luiz Rosalen
Summary: In this study, we investigated the modulatory effects of PI3K gamma on IL-17A expression and the progression of experimental periodontitis in vivo. Our results showed that PI3K gamma inhibitor can attenuate alveolar bone loss and downregulate IL-17A and Rankl gene expression.
INFLAMMATION RESEARCH
(2023)
Article
Infectious Diseases
Felipe Cerni, Isadora Oliveira, Francielle Cordeiro, Karla Bordon, Isabela Ferreira, Wuelton Monteiro, Eliane Arantes, Thiago Cunha, Manuela Pucca
Summary: This study evaluated the pain behavior induced by T. serrulatus venom and its isolated neurotoxins in mice, and found that different neurotoxins caused varying degrees of pain behavior. Additionally, the researchers developed a mice-derived polyclonal antibody targeting Ts5, which was able to neutralize the effect of this neurotoxin and significantly reduce the nociception produced by the whole venom. This study is the first to explore the effects of different classes of T. serrulatus neurotoxins on nociception, and demonstrates the important role of Ts5 in scorpion sting-induced pain.
PLOS NEGLECTED TROPICAL DISEASES
(2023)
Article
Pharmacology & Pharmacy
Sergio M. Borghi, Tiago H. Zaninelli, Telma Saraiva-Santos, Mariana M. Bertozzi, Renato D. R. Cardoso, Thacyana T. Carvalho, Camila R. Ferraz, Doumit Camilios-Neto, Fernando Q. Cunha, Thiago M. Cunha, Felipe A. Pinho-Ribeiro, Rubia Casagrande, Waldiceu A. Verri
Summary: In this study, the researchers investigated the effect of pentoxifylline (Ptx) on delayed-onset muscle soreness (DOMS) in untrained mice exposed to intense acute swimming exercise. They found that Ptx treatment reduced mechanical hyperalgesia caused by intense acute swimming in a dose-dependent manner. Ptx also inhibited neutrophil recruitment, oxidative stress, and cytokine production in the muscle tissue and spinal cord, as well as reduced glial cell activation in the spinal cord. These findings suggest that Ptx can alleviate pain in DOMS by targeting peripheral and spinal cord mechanisms.
FRONTIERS IN PHARMACOLOGY
(2023)
Article
Cell Biology
N. B. Amaral, T. S. Rodrigues, M. C. Giannini, M. I. Lopes, L. P. Bonjorno, P. I. S. O. Menezes, S. M. Dib, S. L. G. Gigante, M. N. Benatti, U. C. Rezek, L. L. Emrich-Filho, B. A. Sousa, S. C. L. Almeida, R. Luppino-Assad, F. P. Veras, A. H. Schneider, L. O. S. Leiria, L. D. Cunha, J. C. Alves-Filho, T. M. Cunha, E. Arruda, C. H. Miranda, A. Pazin-Filho, M. Auxiliadora-Martins, M. C. Borges, B. A. L. Fonseca, V. R. Bollela, C. M. Del-Ben, F. Q. Cunha, R. C. Santana, F. C. Vilar, D. S. Zamboni, P. Louzada-Junior, R. D. R. Oliveira
Summary: This study evaluated whether colchicine treatment was associated with the inhibition of NLRP3 inflammasome activation in patients with COVID-19. The results showed that colchicine reduced the need for supplemental oxygen and the length of hospitalization, and lowered the serum levels of Casp1p20 and IL-18 in the first two days of treatment.
INFLAMMATION RESEARCH
(2023)
Article
Immunology
Tamara S. Rodrigues, Camila C. S. Caetano, Keyla S. G. de Sa, Leticia Almeida, Amanda Becerra, Augusto Goncalves, Leticia de Sousa Lopes, Samuel Oliveira, Danielle P. A. Mascarenhas, Sabrina S. Batah, Bruna M. Silva, Giovanni F. Gomes, Ricardo Castro, Ronaldo B. Martins, Jonathan Avila, Fabiani G. Frantz, Thiago M. Cunha, Eurico Arruda, Fernando Q. Cunha, Helder Nakaya, Larissa D. Cunha, Alexandre T. Fabro, Paulo Louzada-Junior, Rene D. R. de Oliveira, Dario S. Zamboni
Summary: SARS-CoV-2 infection activates the NLRP3 inflammasome and leads to inflammation and severe COVID-19. Human caspase-4 (mouse caspase-11) is upregulated and activated by SARS-CoV-2, contributing to NLRP3 activation. In vivo studies using transgenic hACE2 humanized mice show that hACE2 Casp11(-/-) mice are protected from disease development, with reduced lung damage, clinical symptoms, and mortality. Analysis of human samples from fatal COVID-19 cases reveals the expression of CASP4 in patient lungs, which correlates with inflammasome components and inflammatory mediators. These findings suggest CASP4/11 as a potential target for therapeutic interventions in COVID-19.
JOURNAL OF INFECTIOUS DISEASES
(2023)
Article
Biochemistry & Molecular Biology
Carolina P. Bernardes, Neife A. G. Santos, Tassia R. Costa, Danilo L. Menaldo, Flavia M. Sisti, Martin K. Amstalden, Diego L. Ribeiro, Lusania M. G. Antunes, Suely V. Sampaio, Antonio C. Santos
Summary: In this study, the snake-venom-based tripeptide BTX-I was chemically modified to enhance its neurotrophic and neuroprotective effects. The ethyl-esterified peptide BTX-II showed significant improvement in promoting neuritogenesis and upregulating proteins and genes associated with cognitive improvements.
INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS
(2023)
Article
Respiratory System
Flavio P. Veras, Giovanni F. Gomes, Bruna M. S. Silva, Diego B. Caetite, Cicero J. L. R. Almeida, Camila Meirelles S. Silva, Ayda H. Schneider, Emily S. Corneo, Caio S. Bonilha, Sabrina S. Batah, Ronaldo Martins, Eurico Arruda, Alexandre T. Fabro, Jose C. Alves-Filho, Thiago M. Cunha, Fernando Q. Cunha
Summary: COVID-19 is characterized by severe lung injury due to neutrophil infiltration and release of neutrophil extracellular traps (NETs). This study demonstrates that treatment with DNase I, which degrades NETs, improves clinical symptoms and reduces lung, heart, and kidney injuries in a COVID-19 mouse model.
RESPIRATORY RESEARCH
(2023)
Article
Multidisciplinary Sciences
Tristram A. J. Ryan, Alexander Hooftman, Aisling M. Rehill, Matt D. Johansen, Eoin C. O'Brien, Juliana E. Toller-Kawahisa, Mieszko M. Wilk, Emily A. Day, Hauke J. Weiss, Pourya Sarvari, Emilio G. Vozza, Fabian Schramm, Christian G. Peace, Alessia Zotta, Stefan Miemczyk, Christina Nalkurthi, Nicole G. Hansbro, Gavin McManus, Laura O'Doherty, Siobhan Gargan, Aideen Long, Jean Dunne, Cliona Ni Cheallaigh, Niall Conlon, Michael Carty, Padraic G. Fallon, Kingston H. G. Mills, Emma M. Creagh, James S. O'Donnell, Paul J. Hertzog, Philip M. Hansbro, Rachel M. McLoughlin, Malgorzata Wygrecka, Roger J. S. Preston, Zbigniew Zaslona, Luke A. J. O'Neill
Summary: Excessive inflammation-associated coagulation is a major cause of mortality in infectious diseases. Recent research has found that type I interferon signaling is necessary for the release of tissue factor, a critical initiator of coagulation, providing an important link between innate immunity and coagulation. DMF and 4-OI inhibit tissue factor-mediated coagulopathy through suppression of macrophage type I IFN-TF axis.
NATURE COMMUNICATIONS
(2023)